Technical Analysis for ACUR - Acura Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.59 10.28% 0.06
ACUR closed up 10.28 percent on Wednesday, April 26, 2017, on 21 percent of normal volume.

Earnings due: May 1

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ACUR trend table...

Date Alert Name Type % Chg
Apr 26 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Apr 25 NR7 Range Contraction 10.28%
Apr 25 Narrow Range Bar Range Contraction 10.28%
Apr 25 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 10.28%
Apr 24 Bollinger Band Squeeze Range Contraction 11.32%
Apr 24 180 Bearish Setup Bearish Swing Setup 11.32%
Apr 21 Bollinger Band Squeeze Range Contraction 0.00%
Apr 20 Bollinger Band Squeeze Range Contraction 9.26%
Apr 20 180 Bearish Setup Bearish Swing Setup 9.26%
Apr 19 Bollinger Band Squeeze Range Contraction 0.00%

Older signals for ACUR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies. Its products include Oxecta Tablets CII, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed, an over-the-counter immediate-release pseudoephedrine HCl tablet that is used as a nasal decongestant in various non-prescription and prescription cold, sinus, and allergy products. The company has seven additional opioid products utilizing Aversion technology in various stages of development. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc., a wholly-owned subsidiary of Pfizer Inc. to develop and commercialize certain opioid analgesic products utilizing the company’s proprietary Aversion technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.
Is ACUR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 3.39
52 Week Low 0.46
Average Volume 118,544
200-Day Moving Average 1.0912
50-Day Moving Average 0.5941
20-Day Moving Average 0.5668
10-Day Moving Average 0.5655
Average True Range 0.0633
ADX 8.93
+DI 17.78
-DI: 13.33
Chandelier Exit (Long, 3 ATRs) 0.4601
Chandelier Exit (Short, 3 ATRs) 0.7099
Upper Bollinger Band 0.6152
Lower Bollinger Band 0.5184
Percent B (%b) 0.74
Bandwidth 0.170783